Market Cap | 36.25M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -2.38M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 1.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -21.00% |
Recommedations | - | Quick Ratio | 0.02 | Shares Outstanding | 0.97B | 52W Low Chg | 153.00% |
Insider Own | 60.30% | ROA | -103.25% | Shares Float | 590.19M | Beta | 0.31 |
Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.04 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 4,758 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 100 | Change | 18.66% |
Citrine Global Corp. operates as a plant-based wellness and pharma solutions company in Israel. The company focuses on developing plant-based products to enhance quality of life, and complementary solutions for balancing side effects caused by using medicines, cannabis, treatments, or an unbalanced lifestyle. It offers SmokLy sprays for cannabis users and tobacco smokers; and DryLess sprays for adult population with constant dry mouth, and other cancer treatment patients with constant dry mouth as part of their cancer treatment regimen. The company was formerly known as TechCare Corp. and changed its name to Citrine Global Corp. in August 2020. Citrine Global Corp. was incorporated in 2010 and is headquartered in Caesarea, Israel.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
KRETZMER DAVID | Director Director | Oct 24 | Buy | 0.03 | 250,000 | 7,500 | 250,000 | 10/26/22 |